Bhaskar et al., reported CX3CR1 deficiency worsened tau phosphorylation and brain inflammation in the tau-pathology mouse model of AD hTau mice [39], confirming that different experiments give rise to different effects, either beneficial or detrimental, depending on the mouse model used. This evidence concerns the gene MAPT and Alzheimer disease.